CoChat

Novel Pheochromocytoma Susceptibility Loci Identified by Integrative Genomics

Dahia, Patricia L.M., Hao, Ke, Rogus, John, Colin, Christian, Pujana, Miguel A.G., Ross, Ken, Magoffin, Danielle, Aronin, Neil, Cascon, Alberto, Hayashida, César Y., Li, Cheng, Toledo, Sérgio P.A., Stiles, Charles D., for the Familial Pheochromocytoma Consortium · 2005 · Cancer Research
Cited by 90

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Pheochromocytomas are catecholamine-secreting tumors that result from mutations of at least six different genes as components of distinct autosomal dominant disorders. However, there remain familial occurrences of pheochromocytoma without a known genetic defect. We describe here a familial pheochromocytoma syndrome consistent with digenic inheritance identified through a combination of global genomics strategies. Multipoint parametric linkage analysis revealed identical LOD scores of 2.97 for chromosome 2cen and 16p13 loci. A two-locus parametric linkage analysis produced maximum LOD score of 5.16 under a double recessive multiplicative model, suggesting that both loci are required to develop the disease. Allele-specific loss of heterozygosity (LOH) was detected only at the chromosome 2 locus in all tumors from this family, consistent with a tumor suppressor gene. Four additional pheochromocytomas with a similar genetic pattern were identified through transcription profiling and helped refine the chromosome 2 locus. High-density LOH mapping with single nucleotide polymorphism–based array identified a total of 18 of 62 pheochromocytomas with LOH within the chromosome 2 region, which further narrowed down the locus to <2 cM. This finding provides evidence for two novel susceptibility loci for pheochromocytoma and adds a recessive digenic trait to the increasingly broad genetic heterogeneity of these tumors. Similarly, complex traits may also be involved in other familial cancer syndromes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-05-1427

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 90

Metadata

Authors
Dahia, P. L. M., Hao, K., Rogus, J., Colin, C., Pujana, M. A. G., Ross, K., Magoffin, D., Aronin, N., Cascon, A., Hayashida, C. Y., Li, C., Toledo, S. P. A., Stiles, C. D., & for the Familial Pheochromocytoma Consortium
Venue
Cancer Research
Published
2005-11-01
Volume
65
Issue
21
Pages
9651-9658
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2114208523
Cited by
90
References
4
FWCI
6.77
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel Pheochromocytoma Susceptibility Loci Identified by Integrative Genomics. https://app.cochat.ai/papers/10.1158/0008-5472.can-05-1427
The paper
Dahia, P. L. M., Hao, K., Rogus, J., Colin, C., Pujana, M. A. G., Ross, K., Magoffin, D., Aronin, N., Cascon, A., Hayashida, C. Y., Li, C., Toledo, S. P. A., Stiles, C. D., & for the Familial Pheochromocytoma Consortium. (2005). Novel Pheochromocytoma Susceptibility Loci Identified by Integrative Genomics. Cancer Research. https://doi.org/10.1158/0008-5472.can-05-1427

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.